logo
Select company
Select metric
Ticker Information

Ticker

ADCT

Company Name

ADC THERAPEUTICS SA

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSE

ADC THERAPEUTICS SA - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ADCT - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ -199.18M$ -169.94M0%
3/31/2025$ -238.22M$ -149.84M0%
12/31/2024$ -202.64M$ -157.85M0%
9/30/2024$ -171.95M$ -212.82M0%
6/30/2024$ -131.67M$ -216.66M0%
3/31/2024$ -194.45M$ -227.23M0%
12/31/2023$ -148.25M$ -240.05M0%
9/30/2023$ -54.18M$ -178.51M0%
6/30/2023$ -8.59M$ -181.31M0%
3/31/2023$ 37.69M$ -198.56M-526.91%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ADC THERAPEUTICS SA's latest trailing twelve months (TTM) ROE stands at 0%.
  • Over the past 5 years, ADC THERAPEUTICS SA's average ROE has been -165.67%.
  • The median ROE for ADC THERAPEUTICS SA during this period was -136.4%
  • ADC THERAPEUTICS SA reached its highest ROE over the past 5 years at -73.41%.
  • The lowest ROE recorded by ADC THERAPEUTICS SA in the same timeframe -526.91%

ADC THERAPEUTICS SA's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
YMAB : Y-MABS THERAPEUTICS INC -25.4%TRDA : ENTRADA THERAPEUTICS INC -19.33%NKTR : NEKTAR THERAPEUTICS -CDXS : CODEXIS INC -116.8%LXRX : LEXICON PHARMACEUTICALS INC -93.19%SCPH : SCPHARMACEUTICALS INC -XOMA : XOMA ROYALTY CORP -17.1%ALEC : ALECTOR INC -161.98%SGMO : SANGAMO THERAPEUTICS INC -329.53%KURA : KURA ONCOLOGY INC -64.54%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for ADC THERAPEUTICS SA is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Equity [ $ 376.06M ]
(=) ROE [ 0% ]

ADCT - Return on Equity, Last 5 years

-526.91%

Minimum

Mar 31, 2023

-73.41%

Maximum

Dec 31, 2020

-165.67%

Average

-136.4%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.79%
max73.25%
average1.51%
median6.45%
std22.67%